RT Journal
A1 Sarafidis PA, Bakris GL
T1 Use of a single target blood pressure level in type 2 diabetes mellitus for all cardiovascular risk reduction: Comment on “intensive and standard blood pressure targets in patients with type 2 diabetes mellitus”
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2012
FD September 24
VO 172
IS 17
SP 1304
OP 1305
DO 10.1001/archinternmed.2012.4020
UL http://dx.doi.org/10.1001/archinternmed.2012.4020
AB 
The first prospective trial to randomize patients with type 2 DM (T2DM) to target BPs and examine their cardiovascular (CV) outcomes was the UKPDS 38 by the United Kingdom Prospective Diabetes Study Group.2 In that trial, the group randomized to tighter BP control had a mean BP of 144/82 mm Hg and demonstrated significant reductions in DM-related deaths and complications compared with the group randomized to usual control, whose mean systolic BP was 10 mm Hg higher.